|
KMID : 0614720190620050277
|
|
Journal of Korean Medical Association
2019 Volume.62 No. 5 p.277 ~ p.282
|
|
|
Pharmacotherapy for chronic obstructive pulmonary disease
|
|
Jo Yong-Suk
Park Yong-Bum
|
|
|
Abstract
|
|
|
|
Appropriate pharmacologic therapy can reduce symptoms and risk and severity of exacerbations, as well as improve the health status and exercise tolerance of patients with chronic obstructive pulmonary disease. The most important medications for treating chronic obstructive pulmonary disease are inhaled bronchodilators including beta2-agonist and anticholinergics. Inhaled corticosteroids as anti-inflammatory drug should be considered in certain patients with caution considering risk and benefit. The choice within each class depends on the availability of medication and the patient's responses and preferences. Each treatment regimen needs to be individualized as the relationship between severity of symptoms, airflow limitation and severity of exacerbation can differ between patients.
|
|
|
KEYWORD
|
|
|
Pulmonary disease, chronic obstructive, Respiratory therapy
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
 
|